2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow CVT-301: new trials by email Literature Review of CVT-301 trials Research Report on CVT-301
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes CVT-301, Placebo - Idiopathic Parkinson's Disease | Phase 2 | Completed | Acorda Therapeutics | 89 | 2013-04-01 | 2018-08-08 |
| Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes CVT-301, Placebo, Sinemet (carbidopa/levodopa) - Idiopathic Parkinson's Disease | Phase 2 | Completed | Acorda Therapeutics | 25 | 2012-05-01 | 2017-07-27 |
Serbia (2) · United Kingdom (2) · Israel (1) · Italy (1) · United States (1)
Martin Freed, MD (1)